Antivenom PolongaTAb - Protherics

Drug Profile

Antivenom PolongaTAb - Protherics

Alternative Names: PolongaTAb; Russell's viper antivenom PolongaTAb - Protherics

Latest Information Update: 23 Nov 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Protherics
  • Developer Symbion Health
  • Class Antibodies; Antivenins
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Snake venom poisoning

Most Recent Events

  • 12 Jan 2006 Mayne Group is now called Symbion Health
  • 18 Oct 1999 Therapeutic Antibodies has merged with Proteus International to form Protherics
  • 27 Jul 1999 Preregistration for Snake venom poisoning in South-East Asia (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top